Former Chief Medical Officer · Avalo Therapeutics, Inc. (AVTX)

H. Jeffrey Wilkins

A named executive officer of Avalo Therapeutics in every fiscal year CompBrief holds from FY2020 to FY2021. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2021

$1,249,985

Salary $425,000Stock awards $0

FY2020: $1,487,778

3rd of 3 named executive officers at Avalo Therapeutics by FY2021 total.

3 named officers on file for Avalo Therapeutics, FY2021

H. Jeffrey Wilkins’s pay file — $29

  • 2 fiscal years of pay, line by line
  • 1 equity grant, each cited to its filing

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Avalo Therapeutics’s whole pay program stands against its peers

  • Avalo Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on AVTX→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 25, 2022 (DEF 14A).

Free

Get H. Jeffrey Wilkins’s full pay file as a PDF — free

More than this page: up to 10 years of H. Jeffrey Wilkins’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

H. Jeffrey Wilkins compensation by year

Avalo Therapeutics Summary Compensation Table · all 2 fiscal years held
In US dollars, as Avalo Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2020FY2021
Salary$335,534$425,000
Bonus$0$0
Stock awards$0$0
Option awards$974,244$659,405
Non-equity incentive$178,000$165,580
Pension and deferred compensation$0$0
All other$0$0
Total$1,487,778$1,249,985

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Avalo Therapeutics, Inc. DEF 14A filed April 25, 2022, accession 0001628280-22-010113, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Avalo Therapeutics, Inc. filed document, accession 0001628280-22-010113. Every figure is read from that document and cited to the page and table it appears in. Filed April 25, 2022.

$1.5M
$1.2M
FY20
FY21
SalaryNon-equity incentiveOption awards

Equity holdings

unvested awards at FY2021 year-end
TypeUnvested unitsValue at year-endExercise price
Option300,000—$3.32
Option203,125—$4.09

Per the Outstanding Equity Awards at Fiscal Year-End table in Avalo Therapeutics, Inc.'s FY2021 proxy; value at the fiscal year-end close, as the company printed it.

Avalo Therapeutics’s named executive officers, FY2021

as the company reported each
Named executive officerRoleFY2021 total
Michael ColaFormer Chief Executive Officer and former principal executive officer$2,693,811
Schond GreenwayFormer Chief Financial Officer and former principal financial officer$1,676,585
H. Jeffrey Wilkins · this pageFormer Chief Medical Officer$1,249,985

The full Avalo Therapeutics compensation record

free company brief

This page is one person within Avalo Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Avalo Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

H. Jeffrey Wilkins's compensation dossier · One-time report. No refunds.